{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04312",
      "entity_text" : "FC101",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Consistent with the results from the dose response experiments, time-course analysis also revealed that FC101 reduced the proliferation of the glioblastoma cells, as evidenced by a pronounced decrease in cell proliferation 96 h post-FC101 exposure, as compared to the vehicle treated control cells examined at the same time point (XREF_FIG).",
  "reading_complete" : "2020-08-03T17:12:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:11:18Z",
  "trigger" : "reduced",
  "evidence" : [ "FC101 reduced the proliferation" ],
  "pmc_id" : "4121350",
  "score" : 0
}